US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Biotech Top 5 Bull 2X ETF

34.97

-2.9448-7.77%

Volume:582

Turnover:20.35K

Market Cap:2.62M

PE:- -

High:34.97

Open:34.97

Low:34.97

Close:37.91

52wk High:45.88

52wk Low:25.71

Shares:75.00K

Float Shares:75.00K

Volume Ratio:1.29

T/O Rate:0.78%

Dividend:0.76

Dividend Rate:2.19%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

argenx SE Stock (ARGX) Moved Down by 13.36% on Oct 8: A Full Analysis

Argenx Stock Sinks as Scrapped Vyvgart Trial Erases $3.5 Billion Opportunity

Analysts Are Bullish on These Healthcare Stocks: Argenx Se (ARGX), Edgewise Therapeutics (EWTX)

Argenx has ‘good news and bad news’ day, says H.C. Wainwright

Argenx Se : Baird Cuts Target Price to $823 from $932

THOMSON REUTERS

Dow's Nearly 150-Point Fall Led by Losses for Shares of Amgen, Johnson & Johnson

Starbucks Explored Acquisition of Chipotle in Bid to Create Restaurant Industry Mega-Merger

Argenx Down Nearly 13%, on Pace for Largest Percent Decrease Since December 2023

Argenx falls -12.4%

Analysts’ Top Healthcare Picks: Gilead Sciences (GILD), Rhythm Pharmaceuticals (RYTM)

Amgen Stock Forecast: Pipeline Wins Strengthen Growth Story as MariTide Phase 3 Advances

Argenx CEO Change Vindicated by Celiac-Disease Trial Success

Argenx's Vyvgart Trial Setback is Major Negative Surprise

Argenx Shares Plunge After Autoimmune-Disease Trial Halt

Argenx to Discontinue Late-Stage Sjogren's Disease Trial; Shares Down Pre-Bell

MT Newswires Live

Sino Biopharmaceutical Stock Slides 3.3% in Hong Kong

U.S. Futures Sink, European Stocks Down

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Moderna Inc. Stock Rises 4.8%, Outperforms Peers

Vertex to Report Q3 2026 Financial Results, Host Conference Call and Webcast

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/TBXU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TBXU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","market":"US","secType":"STK","nameCN":"Direxion Daily Biotech Top 5 Bull 2X ETF","latestPrice":34.965,"timestamp":1791476844435,"preClose":37.9098,"halted":0,"volume":582,"delay":0,"changeRate":-0.0776791225487867,"floatShares":75001,"shares":75001,"eps":0,"marketStatus":"Trading","change":-2.9448,"latestTime":"10-08 12:35:59 EDT","open":34.965,"high":34.965,"low":34.965,"amount":20347.507446000003,"amplitude":0,"askPrice":34.95,"askSize":400,"bidPrice":34.84,"bidSize":400,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791489600000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":37.9098,"sharesOutstanding":100001,"nav":37.082,"aum":2781178.87,"dividendRate":0.021865,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":37.0661,"preClose":37.9098,"latestTime":"16:10 EDT","volume":6,"amount":227.4588,"timestamp":1791403804668,"change":-0.8437,"changeRate":-0.022255,"amplitude":0},"volumeRatio":1.2908},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","floatShares":75001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.2908,"shares":75001,"dividePrice":0.76452,"high":34.965,"amplitude":0,"preClose":37.9098,"low":34.965,"week52Low":25.71,"pbRate":"--","week52High":45.88,"institutionHeld":0,"latestPrice":34.965,"eps":0,"divideRate":0.021865,"volume":582,"delay":0,"ttmEps":0,"open":34.965,"prevYearClose":31.065,"prevWeekClose":36.95,"prevMonthClose":39.9,"prevQuarterClose":39.9,"fiveDayClose":37.9097,"twentyDayClose":38.8987,"sixtyDayClose":31.7049},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TBXU\",params:#limit:5,,,undefined,":[{"date":"2026-09-22","symbol":"TBXU","amount":0.14204,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-22","defaultRemindTime":1790083800000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-29","payableDate":"2026-09-22","currency":"USD","dateTimestamp":1790049600000,"payDate":"2026-09-29"},{"date":"2026-06-23","symbol":"TBXU","amount":0.11101,"announcedDate":"2026-06-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-23","defaultRemindTime":1782221400000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-23","currency":"USD","dateTimestamp":1782187200000,"payDate":"2026-06-30"},{"date":"2026-03-24","symbol":"TBXU","amount":0.09893,"announcedDate":"2026-03-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-24","defaultRemindTime":1774359000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-24","currency":"USD","dateTimestamp":1774324800000,"payDate":"2026-03-31"},{"date":"2025-12-23","symbol":"TBXU","amount":0.10111,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-31"},{"date":"2025-12-10","symbol":"TBXU","amount":0.31143,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-17","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TBXU\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-17","value":0.31143,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-31","value":0.10111,"currency":"USD"},{"executeDate":"2026-03-24","recordDate":"2026-03-24","paymentDate":"2026-03-31","value":0.09893,"currency":"USD"},{"executeDate":"2026-06-23","recordDate":"2026-06-23","paymentDate":"2026-06-30","value":0.11101,"currency":"USD"},{"executeDate":"2026-09-22","recordDate":"2026-09-22","paymentDate":"2026-09-29","value":0.14204,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TBXU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TBXU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2674009251","title":"argenx SE Stock (ARGX) Moved Down by 13.36% on Oct 8: A Full Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2674009251","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674009251?lang=en_us&edition=fundamental","pubTime":"2026-10-09 00:15","pubTimestamp":1791476125,"startTime":"0","endTime":"0","summary":"• Argenx discontinued its Phase 3 UNITY study for Sjogren's disease due to futility.\n• The trial termination overshadowed positive mid-stage Phase 2 results for FB102.\n• Core commercial products generate robust cash flows despite the late-stage setback.","market":"us","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262206661-market-movers-argx-20261008","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","LU0320765992.SGD","LU0889565916.HKD","IE0034235188.USD","LU0109394709.USD","LU0823416689.USD","LU2324357040.USD","ARGX","IE00B4R5TH58.HKD","TBXU","IE00BJJMRZ35.SGD","IE0002141913.USD","IE00B2B36J28.USD","BK4139","LU0390134368.USD","IE00BJT1NW94.SGD","BK4585","IBB","IE00BFTCPJ56.SGD","BK4505","FMED","BK4588","LU1983260115.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673062420","title":"Argenx Stock Sinks as Scrapped Vyvgart Trial Erases $3.5 Billion Opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2673062420","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673062420?lang=en_us&edition=fundamental","pubTime":"2026-10-08 23:43","pubTimestamp":1791474180,"startTime":"0","endTime":"0","summary":"Argenx was recently dubbed a high-risk, high-reward \"moonshot\" biotech stock, offering investors tremendous upside if clinical trials panned out. On Thursday, investors saw the flip side of that scena","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0034235188.USD","LU0208291251.USD","LU0390134368.USD","ARGX","MEDX","IE00B2B36J28.USD","LU3187612489.SGD","IE00BJJMRZ35.SGD","BK4585","IE00BJT1NW94.SGD","BK4505","LU0320765489.SGD","LU2324357040.USD","NVS","BK4578","LU0211331839.USD","BK4534","BK4532","LU1863844665.USD","IE00B4R5TH58.HKD","FMED","LU0889565916.HKD","TBXU","LU0320765992.SGD","LU1983260115.SGD","IE00BFTCPJ56.SGD","IE0002141913.USD","BK4007","IBB","LU0109394709.USD","UBS","IE0009355771.USD","IE0034235071.USD","LU0823416689.USD","BK4139","BK4118","LU0070302665.USD","PPH","LU1829250122.USD","LU1863844749.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673062510","title":"Analysts Are Bullish on These Healthcare Stocks: Argenx Se (ARGX), Edgewise Therapeutics (EWTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673062510","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673062510?lang=en_us&edition=fundamental","pubTime":"2026-10-08 23:20","pubTimestamp":1791472813,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Argenx Se (ARGX) and Edgewise Therapeutics (EWTX) wi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-argenx-se-argx-edgewise-therapeutics-ewtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-argenx-se-argx-edgewise-therapeutics-ewtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B2B36J28.USD","HCSG","BK4588","LU0320765992.SGD","LU0889565916.HKD","LU1983260115.SGD","BK4007","LU0029874061.USD","LU0109394709.USD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","BK4139","LABU","BK4581","FMED","LU0823416689.USD","XLV","IBB","LU2324357040.USD","IE00BFTCPJ56.SGD","LU0390134368.USD","BK4505","IE0034235188.USD","IE0002141913.USD","IE0009355771.USD","TBXU","BK4137","BK4539","XBI","LU0128526141.USD","ARGX","BK4585","EWTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673006958","title":"Argenx has ‘good news and bad news’ day, says H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2673006958","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673006958?lang=en_us&edition=fundamental","pubTime":"2026-10-08 23:00","pubTimestamp":1791471615,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Douglas Tsao says Argenx (ARGX) is having a “good news and bad news” day. The company announced positive topline results fr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/argenx-has-good-news-and-bad-news-day-says-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/argenx-has-good-news-and-bad-news-day-says-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARGX","IE00B2B36J28.USD","TBXU","IE00BJJMRZ35.SGD","LU0109394709.USD","BK4585","LU0823416689.USD","BK4139","IE0034235188.USD","IE00B4R5TH58.HKD","LU1983260115.SGD","IE0002141913.USD","BK4505","IBB","LU0889565916.HKD","IE00BJT1NW94.SGD","LU0320765992.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD","BK4588","FMED","LU2324357040.USD","LU0390134368.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673300541","title":"Argenx Se : Baird Cuts Target Price to $823 from $932","url":"https://stock-news.laohu8.com/highlight/detail?id=2673300541","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673300541?lang=en_us&edition=fundamental","pubTime":"2026-10-08 22:58","pubTimestamp":1791471537,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nFWN45U20K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBB","IE00BFTCPJ56.SGD","LU0823416689.USD","IE0034235188.USD","BK4505","LU0390134368.USD","LU0109394709.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","BK4585","IE0002141913.USD","BK4139","IE00B4R5TH58.HKD","IE0009355771.USD","LU0320765992.SGD","LU2324357040.USD","LU0889565916.HKD","IE00BJT1NW94.SGD","BK4588","FMED","ARGX","TBXU","LU1983260115.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673800513","title":"Dow's Nearly 150-Point Fall Led by Losses for Shares of Amgen, Johnson & Johnson","url":"https://stock-news.laohu8.com/highlight/detail?id=2673800513","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673800513?lang=en_us&edition=fundamental","pubTime":"2026-10-08 22:51","pubTimestamp":1791471060,"startTime":"0","endTime":"0","summary":"DJ Dow's Nearly 150-Point Fall Led By Losses For Shares Of Amgen, Johnson & JohnsonThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen and Johnson & Johnson are trading lower Thursday morning, dragging the Dow Jones Industrial Average into negative territory.The Dow  was most recently trading 142 points, or 0.3%, lower, as shares of Amgen  and Johnson & Johnson  have contributed to the index's intraday decline.Amgen's shares are off $10.59, or 2.6%, while those of Johnson & Johnson are down $5.85, or 2.3%, combining for a roughly 98-point drag on the Dow.Also contributing significantly to the decline are Merck , UnitedHealth , and Boeing .A $1 move in any of the benchmark's 30 components equates to a 5.94-point swing.Data source: Dow Jones Market Data, FactSet. Data compiled October 8, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1043141396.HKD","LU1496350502.SGD","LU0234570918.USD","LU2023250330.USD","BK4533","SGXZ80539844.SGD","IE00BDGV0183.EUR","DVY","LU2417539215.USD","MYMmain","BK4585","MISL","LU0943347566.SGD","LU1221951046.USD","LU1032466523.USD","SG9999013999.USD","LU0162691827.USD","LU0210536198.USD","BK4599","IE00BJT1NW94.SGD","LU0466842654.USD","LU0792757196.USD","LU0949170772.SGD","LU2089984988.USD","DJX","DOG","ITA","LU0345770308.USD","DDM","LU2129689605.HKD","BK4568","LU0545562505.USD","BK4592","LU0320765992.SGD","LU1551013425.SGD","LU1057294990.SGD","LU1244550494.USD","IE00BKVL7J92.USD","LU1732799900.SGD","LU2471134796.USD","BK4534","LU0868494617.USD","LU0122379950.USD","BK4187","IYH","LU0964807845.USD","SG9999002224.SGD","TBXU","IE000M9KFDE8.USD","LU0472753341.HKD","LU1291159041.SGD","LU0994945656.USD","GRNY","LU0545039389.USD","IE00BVYPNW00.USD","LU1267930813.SGD","LU1929549753.HKD","LU1003077747.HKD","SG9999001176.SGD","LU2326559502.SGD","IE00BGHQF631.EUR","LU1435385759.SGD","LU1935042991.SGD","SDY","LU1430594728.SGD","LU1894683264.USD","LU1989771016.USD","LU1121112475.USD","LU1506573853.SGD","LU2756315318.SGD","BK4581","LU1066053197.SGD","LU0124676726.USD","LU0640476718.USD","IE00BZ1G4Q59.USD","LU0072461881.USD","LU0511384066.AUD","LU2236285917.USD","LU1585245621.USD","LU2112291526.USD","TRUH","IE000WAW04H5.SGD","IBB","LU2133065610.SGD",".DJI","LU0683600562.USD","LU0820561818.USD","LU0114720955.EUR","LU0203347892.USD","LU2471134952.CNY","TOPT","BK4588","IE00BLSP4452.SGD","LU1059921491.USD","LU0210528500.USD","BA","LU0345769128.USD","LU2242646821.SGD","LU2471134523.USD","LU0058720904.USD","IE00BFTCPJ56.SGD","IE00BFXG1179.USD","LU1894683348.USD","LU2505996509.AUD","BK4504","DIA","LU2505996681.GBP","LU2750360997.AUD","UDOW","FTXH","IE0034235303.USD","LU0795875169.SGD","LU1162221912.USD","LU2896262040.SGD","LU1571399168.USD","LU0426412945.USD","LU1983299246.USD","LU2129689431.USD","LU0289739343.SGD","LU2756315664.SGD","LU2471134879.HKD","IE0002270589.USD","LU0787776722.HKD","LU1244550577.SGD","LU0234572021.USD","IE000SO60NU8.SGD","SG9999001440.SGD","FDN","BK4551","LU0203345920.USD","IE00BJJMRZ35.SGD","XLI","LU2750360641.GBP","IHE","BK4566","LU1261432733.SGD","IE000MB6IJN5.SGD","LU0053666078.USD","PJP","LU1066051225.USD","BBH","LU0985320562.USD","LU0820561909.HKD","GDOC","YMAX","LU2129689514.USD","BK4532","LU0882574055.USD","LU2347655156.SGD","LU0070217475.USD","LU0689472784.USD","BK4550","LU0889565916.HKD","IE0002141913.USD","LU1145028129.USD","LU2592432038.USD","SDOW","IE0001KFT4U8.USD","BOEU","PPA","LU2403377893.USD","SG9999002232.USD","LU2242652126.USD","IDEF","MEDX","LU0889566641.SGD","BIB","IE000F7OJYX1.SGD","FOWF","DJIA","XLV","VUG","IE00B1BXHZ80.USD","IE0009355771.USD","LU0738911758.USD","LU1629891620.HKD","FHLC","LU0661504455.SGD","IE00B4R5TH58.HKD","LU1066051811.HKD","IE00BN8TJ469.HKD","LU0553294199.USD","LU2468319806.SGD","LU0345770993.USD","LU0098860793.USD","IE00BLSP4239.USD","IE00B42XCP33.USD","DGRW","BK4139","BK4564","IBBQ","IE00B19Z3581.USD","LU0912757837.SGD","IE00BSNM7G36.USD","BK4559","LU1228905037.USD","LU1196500208.SGD","LU0289739699.SGD","LU0426417589.USD","LU1244550221.USD","NATO","IE00BVYPNV92.GBP","LU1066051498.USD","SCHD","VHT","04332","LU1221951129.SGD","LU1674673691.USD","LU1718418525.SGD","LU1674673428.USD","BMED","JNJ","LU2602419157.SGD","IE0000B7K699.USD","IE00B19Z3B42.SGD","VYM","DGRO","LU1061106388.HKD","LU1074936037.SGD","LU1023059063.AUD","IE00B2B36J28.USD","BK4007","IE00B7SZLL34.SGD","LU0069063385.USD","LU0109394709.USD","LU0820562030.AUD","LU2430703251.USD","LU0057025933.USD","MGK","LU0320765646.SGD","LU1043141123.HKD","LU1228905540.USD","LU1551013342.USD","BOEG","LU2213496289.HKD","LU1280957306.USD","LU0289961442.SGD","BOED","LU2430703095.HKD","AMGN","LU0689626769.HKD","SG9999001176.USD","RXL","IE00B3PB1722.GBP","JDOC","LU1914381329.SGD","LU1429558221.USD","SGXZ57979304.SGD","IE00B3T34201.USD","DXD","LU2430703178.SGD","LU2456880835.USD","VYMI","LU0345769631.USD","LU0432979614.USD","LU1732800096.USD","SCHG","IE00BBT3K403.USD","LU1778281490.HKD","PBE","FDVV","BK4516","LU0795875086.SGD","LU2487616109.SGD","LU1032955483.USD","IE000BZT7R73.USD","IXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178666966","title":"Starbucks Explored Acquisition of Chipotle in Bid to Create Restaurant Industry Mega-Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=1178666966","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178666966?lang=en_us&edition=fundamental","pubTime":"2026-10-08 22:20","pubTimestamp":1791469222,"startTime":"0","endTime":"0","summary":"Starbucks held discussions about acquiring Chipotle Mexican Grill, a grand plan that would merge two of America's most recognized consumer brands and, if completed, would rank as the largest merger...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","BK4610","PSP","BK4504","IYH","BK4209","PRVT","IEFN","DFMC","AAUM","BK4535","ACTV","PBJ","SBUX","BK4588","PEVC","FFSM","PBPH","RFG","MNA","TMED","CANC","EATZ","VXF","LU0882574139.USD","RSPH","BK4585","MMID","TBXU","GTPE","IE00B3T34201.USD","LU0823411888.USD","SBU","UYG","XLFI","BREW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673400351","title":"Argenx Down Nearly 13%, on Pace for Largest Percent Decrease Since December 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=2673400351","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673400351?lang=en_us&edition=fundamental","pubTime":"2026-10-08 22:10","pubTimestamp":1791468600,"startTime":"0","endTime":"0","summary":"argenx SE Sponsored ADR  is currently at $807.98, down $120.46 or 12.97%--Would be lowest close since June 2, 2026, when it closed at $802.17--On pace for largest percent decrease since Dec. 20, 2023, when it fell 25.12%--Currently down seven of the past eight days--Currently down two consecutive days; down 13.17% over this period--Worst two day stretch since the two days ending Dec. 21, 2023, when it fell 21.75%--Down 15.74% month-to-date--Down 3.92% year-to-date; on pace for worst year on record --Down 23.7% from its all-time closing high of $1058.90 on Aug. 27, 2026--Up 0.38% from 52 weeks ago , when it closed at $804.90--Down 23.7% from its 52-week closing high of $1058.90 on Aug. 27, 2026--Up 21.7% from its 52-week closing low of $663.93 on March 20, 2026--Traded as low as $806.66; lowest intraday level since June 3, 2026, when it hit $793.20--Down 13.12% at today's intraday low; largest intraday percent decrease since May 8, 2025, when it fell as much as 15.06%All data as of 10:0","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0390134368.USD","IE0034235188.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","TBXU","BK4139","IE00B2B36J28.USD","LU0109394709.USD","LU2324357040.USD","ARGX","BK4585","IE00B4R5TH58.HKD","IBB","IE0002141913.USD","BK4505","LU0320765992.SGD","LU0889565916.HKD","BK4588","IE00BJT1NW94.SGD","LU1983260115.SGD","FMED","IE00BJJMRZ35.SGD","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673003149","title":"Argenx falls -12.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673003149","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673003149?lang=en_us&edition=fundamental","pubTime":"2026-10-08 22:00","pubTimestamp":1791468014,"startTime":"0","endTime":"0","summary":"Argenx (ARGX) is down -12.4%, or -$115.19 to $813.25. Published first on TheFly – the ultimate source for real-time, market-moving breaking financi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/argenx-falls-12-4-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/argenx-falls-12-4-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARGX","IE00B2B36J28.USD","TBXU","IE00BJJMRZ35.SGD","LU0109394709.USD","BK4585","LU0823416689.USD","BK4139","IE0034235188.USD","IE00B4R5TH58.HKD","LU1983260115.SGD","IE0002141913.USD","BK4505","IBB","LU0889565916.HKD","IE00BJT1NW94.SGD","LU0320765992.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD","BK4588","FMED","LU2324357040.USD","LU0390134368.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673133072","title":"Analysts’ Top Healthcare Picks: Gilead Sciences (GILD), Rhythm Pharmaceuticals (RYTM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673133072","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673133072?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:10","pubTimestamp":1791461430,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Gilead Sciences (GILD) and Rhythm Pharmaceuticals (R...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-gilead-sciences-gild-rhythm-pharmaceuticals-rytm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-gilead-sciences-gild-rhythm-pharmaceuticals-rytm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GILD","IBB","LU0234570918.USD","LU0965508806.USD","BK4585","LU0882574055.USD","LU0965509010.AUD","LU1674673428.USD","IE00B3T34201.USD","LU1934455277.USD","LU2357627491.SGD","TMED","BK4583","IE00BZ1G4Q59.USD","LU1934455863.HKD","XBI","LU2324357040.USD","TBXU","LU2468319806.SGD","IE00B19Z3581.USD","BK4137","LU0058720904.USD","LU1023059063.AUD","LU2112291526.USD","LU2089984988.USD","IE00B7SZLL34.SGD","BIB","IE0002270589.USD","BK4568","LABU","SG9999015986.USD","BK4566","LU0029874061.USD","LU0965509283.SGD","LU1066053197.SGD","SG9999015978.USD","LU0965509101.SGD","MEDI","LU1037948897.HKD","LU0823416689.USD","XLV","IE00B19Z3B42.SGD","BBH","BK4532","LU0320765992.SGD","HCSG","RYTM","IBBQ","BMED","LU1934455194.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673072511","title":"Amgen Stock Forecast: Pipeline Wins Strengthen Growth Story as MariTide Phase 3 Advances","url":"https://stock-news.laohu8.com/highlight/detail?id=2673072511","media":"TradingKey","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673072511?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:00","pubTimestamp":1791460800,"startTime":"0","endTime":"0","summary":"TradingKey - Amgen enters October with fresh Phase 3 pipeline wins, strong growth from Repatha and Imdelltra, and MariTide advancing across a broad obesity program.","market":"us","thumbnail":"https://resource.tradingkey.com/uploads/20261008/AMGEN-7bfb3accd08d40ba905f9cb7227c2a13.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20261008/AMGEN-7bfb3accd08d40ba905f9cb7227c2a13.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/analysis/stocks/us-stocks/262205484-amgen-amgn-stock-forecast-october-8-2026-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242646821.SGD","PJP","IE0009355771.USD","LU0320765992.SGD","BK4599","LU0889565916.HKD","AMGN","LU0109394709.USD","IE00B4R5TH58.HKD","PBE","LU2468319806.SGD","SG9999001440.SGD","LU1057294990.SGD","TBXU","IE00BJJMRZ35.SGD","IE0002141913.USD","LU2242652126.USD","LU0122379950.USD","IE00B2B36J28.USD","LU1023059063.AUD","BK4581","BK4533","BK4139","LU1983299246.USD","LU1061106388.HKD","BK4566","LU0868494617.USD","LU0289739699.SGD","IBBQ","BIB","IE00BJT1NW94.SGD","BK4585","LU2089984988.USD","IBB","LU2112291526.USD","IE00BFTCPJ56.SGD","LU0058720904.USD","BBH","BK4534","BK4588","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673074881","title":"Argenx CEO Change Vindicated by Celiac-Disease Trial Success","url":"https://stock-news.laohu8.com/highlight/detail?id=2673074881","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673074881?lang=en_us&edition=fundamental","pubTime":"2026-10-08 19:41","pubTimestamp":1791459660,"startTime":"0","endTime":"0","summary":"1140 GMT - Argenx's positive results for a midstage clinical trial in celiac disease vindicates its CEO change earlier this year, Bernstein analysts say in a research note. The Amsterdam-based biotech company said a drug candidate it acquired through its Forte Biosciences deal, FB102, hit the goal in a study, reinforcing the potential of a medicine being tested for two diseases with little or no existing nonsystemic drug treatment options, the analysts say. \"A key rationale for the CEO transition was to diversify the organic pipeline with external innovation,\" the analysts add. Argenx separately said it would discontinue a trial for its main drug Vyvgart in Sjogren's disease. This should come as little surprise given that Sjogren's is a heterogeneous disease that has become a research-and-development \"graveyard\" for the industry, according to Bernstein. Shares fall 16%.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","BK4585","BK4505","LU0390134368.USD","BK4588","IE00B2B36J28.USD","BK4139","IE0034235188.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU2324357040.USD","FMED","IBB","LU1983260115.SGD","ARGX","LU0889565916.HKD","TBXU","IE00BJJMRZ35.SGD","LU0320765992.SGD","IE0002141913.USD","IE0009355771.USD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673207168","title":"Argenx's Vyvgart Trial Setback is Major Negative Surprise","url":"https://stock-news.laohu8.com/highlight/detail?id=2673207168","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673207168?lang=en_us&edition=fundamental","pubTime":"2026-10-08 19:25","pubTimestamp":1791458700,"startTime":"0","endTime":"0","summary":"1125 GMT - Argenx's decision to stop a late-stage clinical trial of its Vyvgart drug in Sjogren's disease comes as a major negative surprise for the European biotech company, UBS analysts say in a note. \"We believe Argenx's discontinuation of Sjogren's study at interim suggests potentially very little efficacy--if any--not just a 'near miss',\" the analysts say. The drug had generated positive and solid results in a midstage study, as had a similar medicine from rival Johnson & Johnson, Imaavy, they add. The study was supposed to be one of the most closely watched updates from Argenx next year, and UBS had modeled peak annual sales for Vyvgart in Sjogren's at $3.5 billion, the analysts say. Shares fall 16%.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BJT1NW94.SGD","LU0109394709.USD","BK4505","TBXU","LU1983260115.SGD","IE00BJJMRZ35.SGD","IE0034235188.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","IE0002141913.USD","ARGX","LU0320765992.SGD","IE00B2B36J28.USD","LU2324357040.USD","BK4588","LU0889565916.HKD","BK4139","IE0009355771.USD","LU0390134368.USD","IBB","FMED","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673073378","title":"Argenx Shares Plunge After Autoimmune-Disease Trial Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2673073378","media":"Dow Jones","labels":["EditorSelect","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673073378?lang=en_us&edition=fundamental","pubTime":"2026-10-08 17:55","pubTimestamp":1791453300,"startTime":"0","endTime":"0","summary":"Argenx shares fell sharply after the biotech company stopped a late-stage clinical trial of its Vyvgart drug due to lack of efficacy for the treatment of autoimmune condition Sjogren's disease.Shares ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"EditorSelect,movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FMED","IBB","IE00B4R5TH58.HKD","LU0109394709.USD","BK4505","IE0002141913.USD","ARGX","IE00BFTCPJ56.SGD","TBXU","LU0889565916.HKD","BK4139","IE00B2B36J28.USD","LU1983260115.SGD","IE00BJJMRZ35.SGD","LU0320765992.SGD","LU2324357040.USD","IE0009355771.USD","BK4588","LU0390134368.USD","LU0823416689.USD","BK4585","IE00BJT1NW94.SGD","IE0034235188.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673022772","title":"Argenx to Discontinue Late-Stage Sjogren's Disease Trial; Shares Down Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2673022772","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673022772?lang=en_us&edition=fundamental","pubTime":"2026-10-08 16:38","pubTimestamp":1791448725,"startTime":"0","endTime":"0","summary":"Argenx  will discontinue a phase 3 study of efgartigimod subcutaneous in adults with moderate-to-severe Sjogren's disease after an independent data monitoring committee recommended stopping the trial for futility, the company said Thursday.The committee concluded that the study was unable to meet its primary endpoint, while safety remained consistent with efgartigimod's established profile, according to the company.Separately, Argenx said a phase 2 study of FB102 in adults with celiac disease met its primary endpoint, showing a \"statistically significant and clinically relevant\" treatment effect, compared with placebo.The observed safety profile was consistent with previous studies and the known safety profile of FB102, with no new safety signals identified. The company plans to advance FB102 into phase 3 development, it said.Sjogren's disease is a chronic, slowly progressive, inflammatory systemic autoimmune disease characterized by destruction of the exocrine glands. Celiac disease i","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0320765992.SGD","IE00B4R5TH58.HKD","BK4588","IE00BJT1NW94.SGD","IBB","IE00BFTCPJ56.SGD","TBXU","LU0109394709.USD","LU0823416689.USD","IE0034235188.USD","LU0390134368.USD","BK4139","IE00B2B36J28.USD","LU1983260115.SGD","LU0889565916.HKD","ARGX","BK4585","IE00BJJMRZ35.SGD","BK4505","IE0009355771.USD","FMED","IE0002141913.USD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673022200","title":"Sino Biopharmaceutical Stock Slides 3.3% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2673022200","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673022200?lang=en_us&edition=fundamental","pubTime":"2026-10-08 16:32","pubTimestamp":1791448320,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slipped 3.3% to 5.49 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.4% to 23785.79.This was the stock's second consecutive day of losses.Sino Biopharmaceutical Ltd. closed 35% below its 52-week high of HK$8.48, which the company reached Oct. 9.The stock demonstrated a mixed performance when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 5.4% and Amgen Inc. remained unchanged.Trading volume totaled 82.2 million shares, compared to the 50-day average of 79.7 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242652126.USD","HK0000165453.HKD","LU0320765992.SGD","BK1589","IE00B4R5TH58.HKD","BK4588","BK4581","BBH","BK4533","LU2089984988.USD","IE00BJT1NW94.SGD","IE00BZ08YR35.GBP","LU1571399168.USD","IE00BZ08YS42.EUR","BK1521","IBB","IE00BFTCPJ56.SGD","TBXU","LU1983299246.USD","BK4534","PJP","AMGN","01177","BK4599","LU0109394709.USD","LU0122379950.USD","BK1515","LU0289739699.SGD","BK1191","BK4139","IE00B2B36J28.USD","LU1057294990.SGD","SG9999001440.SGD","BIB","LU1061106388.HKD","LU2468319806.SGD","BK4566","LU2242646821.SGD","IE00BZ08YT58.USD","LU2112291526.USD","LU0889565916.HKD","LU0868494617.USD","BK4585","LU1023059063.AUD","LU0058720904.USD","IE00BJJMRZ35.SGD","IE0009355771.USD","PBE","IE0002141913.USD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673021694","title":"U.S. Futures Sink, European Stocks Down","url":"https://stock-news.laohu8.com/highlight/detail?id=2673021694","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673021694?lang=en_us&edition=fundamental","pubTime":"2026-10-08 15:31","pubTimestamp":1791444660,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.U.S. futures for the S&P 500 fell 0.3%, and futures for the Dow Jones Industrial Average declined 0.6%. Changes in futures don't nec","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["US2Y.BOND","IE0009355771.USD","BK4505","LU1983260115.SGD","FMED","IE00B4R5TH58.HKD","US3Y.BOND","IE0002141913.USD","US5Y.BOND","US7Y.BOND","IE00BJJMRZ35.SGD","US10Y.BOND","IE00BJT1NW94.SGD","US6M.BOND","LU0109394709.USD","BK4588","IE00B2B36J28.USD","IE0034235188.USD","ARGX","LU0889565916.HKD","LU0390134368.USD","BK4585","LU0320765992.SGD","TBXU","IE00BFTCPJ56.SGD","BK4139","EPV","US12M.BOND","IBB","US30Y.BOND","LU2324357040.USD","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673048662","title":"Amgen Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2673048662","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673048662?lang=en_us&edition=fundamental","pubTime":"2026-10-08 04:34","pubTimestamp":1791405240,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  rallied 2.60% to $413.08 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.22% to 7,801.77 and Dow Jones Industrial Average  falling 0.66% to 51,179.87.The stock's rise snapped a five-day losing streak.Amgen Inc. closed 7.59% short of its 52-week high of $447.03, which the company reached on August 25th.The stock outperformed some of its competitors Wednesday, as Johnson & Johnson  rose 1.44% to $258.45, Pfizer Inc.  rose 1.82% to $28.00, and AbbVie Inc.  rose 1.75% to $271.36.Trading volume  remained 654,497 below its 50-day average volume of 2.9 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 7, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN","IE00B2B36J28.USD","LU2089984988.USD","TBXU","BK4566","LU1983299246.USD","IE00BJJMRZ35.SGD","LU0109394709.USD","BIB","04332","LU1023059063.AUD","LU1057294990.SGD","BBH","BK4585","LU0868494617.USD","BK4599","LU1061106388.HKD","BK4139","LU2242652126.USD","PBE","SG9999001440.SGD","LU0058720904.USD","BK4534","IE00B4R5TH58.HKD","IE0002141913.USD","IBB","LU0122379950.USD","LU0889565916.HKD","PJP","IE00BJT1NW94.SGD","LU0320765992.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD","BK4588","BK4533","LU0289739699.SGD","LU2242646821.SGD","LU2112291526.USD","LU2468319806.SGD","BK4581","LU1571399168.USD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673483150","title":"Moderna Inc. Stock Rises 4.8%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2673483150","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673483150?lang=en_us&edition=fundamental","pubTime":"2026-10-08 04:33","pubTimestamp":1791405180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. advanced 4.8% to $196.48 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.2% to 27,538.69 and Dow Jones Industrial Average falling 0.7% to 51,179.87.Moderna Inc. closed 7.4% short of its 52-week high of $212.22, which the company achieved on October 6th.The stock outperformed some of its peers, as Johnson & Johnson rose 1.4% to $258.45, Pfizer Inc. rose 1.8% to $28.00, and Gilead Sciences Inc. rose 1.82% to $146.85.Trading volume totaled 14.6 million, compared to the 50-day average of 20.7 million.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0861579265.USD","BMED","BK4578","LU1061106388.HKD","BK4583","LU1839511570.USD","LGHT","LU1674673428.USD","LU1778281490.HKD","LU0965508806.USD","IE00B7SZLL34.SGD","IBB","MEDI","IE0002270589.USD","SG9999015952.SGD","MRNY","LU0109394709.USD","BK4501","BBH","TBXU","BK4550","BK4588","GILD","MRNA","BIB","IE00BSNM7G36.USD","BK4548","TMED","IE00BZ1G4Q59.USD","IE00B3T34201.USD","BK4534","LU0058720904.USD","IE00BKVL7J92.USD","BK4585","LU0965509010.AUD","IE00B19Z3581.USD","MRNX","LU0289739699.SGD","LU2089984988.USD","LU2112291526.USD","WDNA","LU2324357040.USD","BK4566","GNOM","BK4551","IDNA","SG9999015978.USD","SG9999015986.USD","IBBQ","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673106080","title":"Vertex to Report Q3 2026 Financial Results, Host Conference Call and Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2673106080","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673106080?lang=en_us&edition=fundamental","pubTime":"2026-10-08 04:00","pubTimestamp":1791403217,"startTime":"0","endTime":"0","summary":"Vertex to report Q3 2026 financial results, host conference call and webcastVertex will report third-quarter 2026 financial results on Nov. 2, 2026.Conference call and webcast set for Nov. 2, 2026 at ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nNDL13mQMk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","LU1778281490.HKD","LU0058720904.USD","BK4585","LU0234570918.USD","IBBQ","IE00B4R5TH58.HKD","VRTX","LU2362541513.USD","LU1674673691.USD","BK4532","LU1093756325.SGD","TBXU","IE00B19Z9Z06.USD","LU0889565916.HKD","LU2237438978.USD","BK4567","IE0009355771.USD","PBE","BBH","LU2324357040.USD","LU0823416689.USD","LU0432979614.USD","SG9999013999.USD","IE00B894F039.SGD","IDNA","LU2456880835.USD","IE0002141913.USD","LU0079474960.USD","BK4588","LU2468319806.SGD","LU1035775433.USD","LU1674673428.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","GNMX","SG9999001176.SGD","LU2462157665.USD","IE00B19Z9P08.USD","IE00B19Z3B42.SGD","LU0320765992.SGD","SGXZ57979304.SGD","BIB","LU0256863811.USD","IBB","LU1430594728.SGD","SG9999001176.USD","BK4139","LU2089984988.USD","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}